Skip to content

CDR

PharmaSmart kiosks to integrate with PDX

PharmaSmart International Inc. has entered an agreement with PDX Inc. in which PharmaSmart health screening kiosks will be integrated with the PDX Enterprise Pharmacy System and patient clinical data stored in PDX’s Rx.com Enterprise Pharmacy Record.

New coalition makes affordable health coverage its cause

Amid rising public uncertainty about the impact of health care reform, a national group of organizations including large and small employers, pharmacy benefit managers, health providers, health benefits advisers and health plans has formed the Affordable Health Benefits Coalition (AHBC), which aims

Health Mart rolls out local marketing program

Drug store franchise Health Mart has launched a new Local Marketing Support program, designed to help pharmacy owners promote themselves as community health care providers as well as develop new revenue streams.

Nexafed meth-thwarting decongestant to hit Rite Aid shelves

Acura Pharmaceuticals Inc. has gained retail distribution for Nexafed, a pseudoephedrine nasal decongestant with abuse deterrent technology, at Rite Aid pharmacies. Acura has steadily boosted Nexafed’s retail presence since the product’s introduction in December 2012.

Legislation takes aim at ‘medicine cabinet tax’

Legislation takes aim at ‘medicine cabinet tax’

The U.S. Senate has introduced a bill to repeal a provision of the Patient Protection and Affordable Care Act (PPACA) that requires consumers to get a prescription to use a medical savings account to buy over-the-counter medicine. The Restoring Access to Medication Act (S.

Bloom to appear in reality TV show

Mike Bloom, president and chief operating officer of Family Dollar Stores Inc., will be featured on the CBS-TV reality series "Undercover Boss" this week. The episode with Bloom, a longtime executive at CVS Caremark Corp. before joining Family Dollar in 2011, is scheduled to air on Friday, Nov.

Endo to acquire Paladin Labs

Endo Health Solutions plans to acquire Paladin Labs Inc., a Canada-based specialty pharmaceutical company, in a stock and cash deal valued at about $1.6 billion.